Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Acquisitions & Divestments: 2012-2025

Historic Change in Acquisitions & Divestments for Rockwell Medical (RMTI) over the last 7 years, with Sep 2025 value amounting to $3.0 million.

  • Rockwell Medical's Change in Acquisitions & Divestments was N/A to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is 86.91% down from last year.
  • Rockwell Medical's Change in Acquisitions & Divestments amounted to $3.0 million in Q3 2025, which was down 0.00% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Change in Acquisitions & Divestments peaked at $12.0 million during Q1 2022, and registered a low of $1.8 million during Q2 2023.
  • In the last 3 years, Rockwell Medical's Change in Acquisitions & Divestments had a median value of $3.0 million in 2025 and averaged $3.3 million.
  • In the last 5 years, Rockwell Medical's Change in Acquisitions & Divestments slumped by 57.15% in 2021 and then spiked by 77.68% in 2022.
  • Rockwell Medical's Change in Acquisitions & Divestments (Quarterly) stood at $7.6 million in 2021, then fell by 5.19% to $7.2 million in 2022, then tumbled by 44.52% to $4.0 million in 2023, then grew by 11.40% to $2.0 million in 2024, then soared by 49.78% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $3.0 million for Q2 2025, and $3.0 million during Q1 2025.